abstract |
The present invention relates to compounds represented by General Formulas (I) and (I-1), and a preparation method therefor, a use of the compounds in treatment of platelet aggregation-related diseases and in preparation of drugs for treating platelet aggregation-related diseases, and a pharmaceutical composition and a pharmaceutical preparation containing the compounds, wherein in the general formulas, R 1 , R 2 , R 3 and R 2a have the same definitions as those in the specification. |